9 employees
VLST Corporation is developing a novel approach to speed the development of therapeutics to treat inflammatory and autoimmune diseases.
2004
$55M
from 5 investors over 5 rounds
VLST Corp raised $55M on June 16, 2006
Investors: OVP Venture Partners, MPM Capital, Washington Research Foundation, TPG Global and ARCH Venture Partners